Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Raises Target Price to $255
Teleflex Is Maintained at Outperform by RBC Capital
Teleflex Analyst Ratings
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Raises Target Price to $275
BofA Securities Maintains Teleflex(TFX.US) With Hold Rating, Announces Target Price $250
Maintaining Hold on Teleflex Amid Mixed Market Opportunities and Competitive Challenges
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)
Teleflex's Stock Buy Rating: Diverse Portfolio and Strategic Market Advantages Propel Growth
Teleflex Price Target Maintained With a $260.00/Share by RBC Capital
Teleflex Analyst Ratings
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Maintains Target Price $260
RBC Capital Remains a Buy on Teleflex (TFX)
Truist Securities Maintains Hold on Teleflex, Raises Price Target to $247
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Announces Target Price $247
U.S. Stock Market Dynamics: Teleflex rose more than 8% in pre-market trading, and many major banks raised its target price.
Teleflex Price Target Raised to $260.00/Share From $235.00 by RBC Capital
Teleflex Analyst Ratings
BofA Securities Maintains Teleflex(TFX.US) With Hold Rating
Needham Maintains Teleflex(TFX.US) With Hold Rating
A Quick Look at Today's Ratings for Teleflex(TFX.US), With a Forecast Between $243 to $290